ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281613; 2) Community: the network communities that were significantly associated with the response to NSC 281613; 3) Molecule: the relationships between components within communities and NSC 281613; 4) MDR: the compounds that were significantly associated with the NSC 281613.

NSC Compound Enrichment Correlation
NSC 724600 S-(dimethylarsino)-3-mercapto-1,2-propyl diacetate 0.00347157511980527 0.036373602
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.00347157511980527 -0.017266398
NSC 143925 Pekilocerin A 0.00347157511980532 0.32087576
NSC 116789 Acovenoside B 0.00404192617431249 0.4713178
NSC 268965 Benzaldehyde, 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]- 0.00404192617431249 0.82594118
NSC 606985 Camptothecin Derivative 0.00404192617431249 0.45424805
NSC 613327 Gemcitabine Y 0.00404192617431249 0.48574775
NSC 619688 Null 0.00404192617431249 0.30031259
NSC 645566 Null 0.00404192617431249 0.092624655
NSC 664313 Null 0.00404192617431249 0.18234533
Total:61  Current:5    [First] [Prev] [Next] [Last]